
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.890 | 2.140 | 0.250 |
Shares | 98.110 | 98.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.997 | 17.665 |
Price to Book | 4.598 | 3.990 |
Price to Sales | 5.022 | 4.887 |
Price to Cash Flow | 12.504 | 13.886 |
Dividend Yield | 1.048 | 0.516 |
5 Years Earnings Growth | 3.929 | 8.386 |
Number of long holdings: 83
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 10.18 | 123.07 | +0.21% | |
Amgen | US0311621009 | 9.28 | 300.11 | +0.44% | |
Vertex | US92532F1003 | 8.64 | 420.12 | +0.79% | |
AstraZeneca ADR | US0463531089 | 5.68 | 84.28 | -0.48% | |
Alnylam | US02043Q1076 | 4.59 | 486.84 | +1.07% | |
Regeneron Pharma | US75886F1075 | 4.20 | 580.23 | +0.38% | |
Insmed | US4576693075 | 2.84 | 165.47 | -0.18% | |
argenx ADR | US04016X1019 | 2.75 | 851.39 | +0.92% | |
Sanofi ADR | US80105N1054 | 2.51 | 50.45 | -0.34% | |
Summit Therapeutics PLC | US86627T1088 | 2.18 | 20.310 | -3.24% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DE000A2DU1Y2 | 2.43B | -0.15 | -3.20 | 1.46 | ||
Kapital Plus A EUR | 2.43B | -0.82 | 4.42 | 1.67 | ||
Kapital Plus P2 EUR | 2.43B | -0.32 | 5.12 | 2.35 | ||
Kapital Plus I EUR | 2.43B | -0.43 | 4.96 | 2.19 | ||
Kapital Plus P EUR | 2.43B | -0.43 | 4.96 | 2.19 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review